Actionable news
0
All posts from Actionable news
Actionable news in VNDA: Vanda Pharmaceuticals Inc.,

Top Analyst Upgrades and Downgrades: AMD, Chevron, GM, Intel, Merck, Nokia, Under Armour and More

Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) was started as Buy with a $150 price target (versus a $119.92 close) at FBR Capital Markets.

Celgene Corp. (NASDAQ: CELG) was reiterated as Outperform and the price target was raised to $166 from $163 at Oppenheimer. Celgene was down 1.8% at $98.17 on Friday, but that was after falling 16% from $119.56 the prior day. Celgene has a 52-week range of $94.55 to $147.17.

Doctor: How To Lose Your Belly Fat (Do This Every Day)

Century Aluminum Co. (NASDAQ: CENX) was downgraded to Neutral from Overweight at JPMorgan.

Conagra Brands Inc. (NYSE: CAG) was raised to Buy from Hold at Stifel.

Exxon Mobil Corp. (NYSE: XOM) was reiterated as Hold with an $84 price target at Jefferies.

Goodyear Tire & Rubber Co. (NYSE: GT) was downgraded to Neutral from Buy at Citigroup.

J.C. Penney Co. Inc. (NYSE: JCP) was down 14.75% at $3.12 on Friday after lowering its full year guidance. J.C. Penney was downgraded to Sell from Neutral at Citigroup; and J.C. Penney was downgraded to Neutral from Positive at Susquehanna. This stock now has a 52-week range of $2.76 to $10.74.

JD.com Inc. (NASDAQ: JD) was raised to Buy from Neutral with a $48 price target (versus a $37.36 close) at UBS. JD.com has a 52-week range of $23.38 to $48.99.

Leggett & Platt (NYSE: LEG) was downgraded to Neutral from Overweight at Piper Jaffray.

Macy’s Inc. (NYSE: M) was downgraded to Sell from Neutral at Citigroup.

Office Depot Inc. (NYSE: ODP) was downgraded to Underweight from Neutral at JPMorgan. Office Depot closed down 0.25% at $3.72 on Friday, versus a 52-week range of $3.01 to $6.26.

Pandora Media Inc. (NYSE: P) was maintained as Outperform with a $15 price target (versus a $7.20 close) at Wedbush Securities. The firm is expecting third quarter results at the high-end of guidance with progress On EBITDA and subscribers in focus.

Piper Jaffray (NYSE: PJC) was raised to Outperform from Market Perform at Keefe Bruyette & Woods.

Rhythm Pharmaceuticals Inc. (NASDAQ: RTYM) was started as Buy with a $30 price objective at Merrill Lynch. Rhythm Pharma was started as Outperform with a $40 price target at Cowen, and it was started as Equal Wight with a $23 price target at Morgan Stanley. Rhythm Pharma closed up 3.3% at $23.72 on Friday and it has a post-IPO range of $21.38 to $33.81.

Turtle Beach Corp. (NASDAQ: HEAR) was reiterated as Outperform with a $1.50 price target (versus a $0.71 close) at Wedbush. This micro-cap headset maker is said to have an improved execution and has moved beyond issues that hurt it in recent years, and a lower cost structure will help drive EBITDA growth in 2017 and beyond.

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) was reiterated as Outperform and the price target was raised to $26 from $21 (versus a $14.70 close) at Oppenheimer.

Friday’s top analyst upgrades and downgrades included Aetna, Alphabet, Amazon, Celgene, First Solar, Intel, IBM, Microsoft, Tesla, Twitter and many more.

By Jon C. Ogg


More